ADRA1B Antikörper (3rd Cytoplasmic Domain)
Kurzübersicht für ADRA1B Antikörper (3rd Cytoplasmic Domain) (ABIN2469448)
Target
Alle ADRA1B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- 3rd Cytoplasmic Domain
-
Spezifität
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Aufreinigung
- Immunoaffinity Chromatography
-
Immunogen
- ADRA1B antibody was raised against a peptide located in the 3rd cytoplasmic domain of ADRA1B (Human).
-
-
-
-
Applikationshinweise
- ADRA1B antibody can be used in immunohistochemistry starting at 15 - 20 μg/mL.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, 0.1 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- As with all antibodies avoid freeze/thaw cycles.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- ADRA1B antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.
-
-
- ADRA1B (Adrenergic, alpha-1B-, Receptor (ADRA1B))
-
Andere Bezeichnung
- ADRA1B
-
Hintergrund
- The alpha-1b adrenoceptor is an Adrenergic Receptor that causes contraction of smooth muscle cells and thereby controls vascular tone, blood pressure, and accelerates the development of atherosclerosis. Decreased alpha-1b adrenoceptor is associated with benign prostatic hyperplasia (BPH). This adrenergic receptor also acts as a proto-oncogene when transfected into cell lines where constitutive activation of the receptor induces neoplastic transformation.
-
Gen-ID
- 147
-
UniProt
- P35368
-
Pathways
- AMPK Signaling, Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Target
-